@article {2291, title = {Renal Resistive Index and Estimated Glomerular Filtration Rate in Nondiabetic Chronic Kidney Disease Stage 3: A Cross-Sectional Analytical Study}, journal = {Pharmacognosy Journal}, volume = {16}, year = {2024}, month = {June 2024}, pages = {538-544}, type = {Original Article}, chapter = {538}, abstract = {

Background: Renal resistive index (RRI) and estimated glomerular filtration rate (eGFR) are predictive markers for chronic kidney disease (CKD) progression. Aim: To evaluate RRI value, eGFRcr-cys and renal biomarker in nondiabetic patients with CKD stage 3 in Bangkok, Thailand. Methods: A cross-sectional analytical analysis was conducted involving nondiabetic patients with CKD stage 3, aged 35-85 years. Ultrasound was used to assess the RRI of arteries in both kidneys. Patients underwent assessments of serum and urine 24-hour. Results: Among the 61 participants (67.2\% male; mean age 69.03 {\textpm} 12.59 years), the mean eGFRcr-cys was 41.63 {\textpm} 8.64 mL/min/1.73 m{\texttwosuperior}, and the mean RRI was 0.65 {\textpm} 0.06. Patients were categorized into three RRI groups: low (\<0.65, n=35), intermediate (0.65-0.70, n=14), and high (\>0.70, n=12). The high RRI group showed a mean RRI of 0.73 {\textpm} 0.05 (p \< 0.01). Among those with high RRI group were significant decreased right kidney size (p\<0.05) and they had a lower BMI, averaging 22.49 {\textpm} 3.48. An increase in PP (59.66 {\textpm} 13.84, p=0.04) was also significant in this group. The correlations coefficient of RRI value showed a significant positive correlation with age (p\<0.05) and significant negative with BMI (p\<0.05). In addition, eGFRcr-cys displayed a significant negative correlation with UAGT and 24hUP (p\<0.05) and a significant while eGFRcr-cys positive correlation with both kidney size and urine iNOS(p\<0.01). Conclusion: An increase in RRI is inversely linked to age, BMI, and PP. Lower eGFR is correlated with factors that cause CKD progression.

}, doi = {10.5530/pj.2024.16.85}, author = {Patnaree Wongmanit and Kusuma Sriyakul and Parunkul Tungsukruthai and Ouppatham Supasyndh and Pratya Phetkate} } @article {2158, title = {Effect of Plant Stage and Solvent Extraction on Catechin Contents in Borrasus flabellifer L. Male Flower}, journal = {Pharmacognosy Journal}, volume = {15}, year = {2023}, month = {December 2023}, pages = {1036-1041}, type = {Original Article}, chapter = {1036}, abstract = {

Borrasus flabellifer L. is a plant in the Arecaceae (Palmae) family with numerous bioactivities such as diuretic promotion, antioxidant, and antimicrobial effects. In this study, we are interested in the phytochemical compounds present in B. flabellifer L. male flowers. We investigated the effects of plant stage and solvent used for extraction. Initially, both the young and mature male flowers of this plant were extracted using water or ethanol. Several standard compounds, including gallic acid, catechin, caffeic acid, and quercetin, were utilized to screen the phytochemicals in these plant flowers. After analyzing the samples using High-Performance Liquid Chromatography (HPLC) method, only catechin was detected in all extracts, while the others were not detected (did not match the peak spectrum pattern compared with standard). Using a detection wavelength and curve parameters with an R2 value of 0.9999, catechin detection via HPLC was performed at 280 nm within the range of 13.12 to 210.00 {\textmu}g/mL detection. Regarding the stage of the male flower, the young ones extracted with water provided the highest catechin content at 6.65 {\textmu}g/mg extract, while the others fell within the range of 4.02 to 4.44 {\textmu}g/mg extract. Therefore, it has been confirmed that catechin can be found in B. flabellifer L., and water should be used as the solvent for extraction for further applications of this plant.

}, keywords = {Borrasus flabellifer L., Catechin, HPLC, Male flower, Mature, Young}, doi = {10.5530/pj.2023.15.190}, author = {Chayut Fongsuk and Patnaree Wongmanit and Kanoktip Pansuksan} } @article {2149, title = {Safety Assessment of Supplementation with Cymbopogon citratus Stapf. (Lemongrass) Extract in Patients with Chronic Kidney Disease Stage 3: A Preliminary 90-Days Prospective Study}, journal = {Pharmacognosy Journal}, volume = {15}, year = {2023}, month = {December 2023}, pages = {976-986}, type = {Original Article}, chapter = {976}, abstract = {

Background: Chronic kidney disease is a major public health issue, and due to resource constraints, many can{\textquoteright}t access dialysis. C. citratus, lemongrass is globally prevalent and known to increase urine output without toxicity. Objective: To examine the safety of C. citratus in patients with CKD stage 3. Materials and Methods: The major compound of C. citratus was analyzed using high-performance liquid chromatography (HPLC). 64 patients were enrolled and randomly assigned to control or C. citratus groups. The control group received a placebo, whereas the C. citratus group received 900 mg of C. citratus daily for 90 days. All participants were examined BUN, Scr, Cys-C, and eGFR, liver functions, RBC, HCT, Na+, K+, Cl-, and HCO3, and other biochemical parameters. Results: HPLC showed C. citratus contains of phenolic compounds. Clinically, C. citratus group had no notable side effects on T-Bil, AST, ALT and ALP. Also, maintained eGFR, SCys-C, K+ and Cl level. The level of blood Na+ was significant increase at day 30 (p \< 0.05). The control group had a significant decrease in eGFR and HCO3 levels (p \< 0.05) and a significant increase of Cl- and SCys-C. In addition, no statistical differences had found between groups in eGFR, BUN, Cr, Na+, K+, HCO3, PO4, RBC and HCT levels. Throughout the 90 days, no drug allergies or side effects were reported. Conclusion: Dietary supplementation with C. citratus may have a favorable effect on delaying the course of CKD and is safe to use for patients with CKD stage 3.

}, keywords = {Chronic Kidney Disease, CKD stage 3, Cymbopogon citratus Stapf., Lemongrass, Safety}, doi = {10.5530/pj.2023.15.181}, author = {Patnaree Wongmanit and Parunkul Tungsukruthai and Pratya Phetkate and Daraporn Rungprai and Sucharat Tungsukruthai and Ouppatham Supasyndh and Kusuma Sriyakul} }